Crocidolite asbestos elicits oxidative stress and cell proliferation, but the signaling cascades linked to these outcomes are unclear. To determine the role of mitogenactivated protein kinases (MAPK) in asbestos-induced cell signaling, we evaluated the effects of crocidolite asbestos, EGF and H 2 O 2 , on MAPK activation in murine lung epithelial cells (C10 line). In contrast to rapid and transient activation of extracellular signal-regulated kinase 5 (ERK5) by EGF or H 2 O 2 , asbestos caused protracted oxidant-dependent ERK5 activation that was inhibited by an Src kinase inhibitor (PP2), but not by an inhibitor of epidermal growth factor receptor (EGFR) phosphorylation (AG1478). ERK1/2 activation by asbestos was inhibited by either PP2 or AG1478. To confirm the involvement of Src in ERK1/2 and ERK5 activation, a dominant-negative Src construct was used. These experiments showed that Src was essential for ERK1/2and also ERK5 phosphorylation by asbestos. Time frame studies indicated immediate activation of Src by asbestos fibers, whereas EGFR phosphorylation occurred subsequently. Data suggest that asbestos causes activation of ERK5 through an EGFR-independent pathway, whereas ERK1/ 2 activation is dependent on Src through a mechanism involving phosphorylation of the EGFR. Furthermore, Src, ERK1/2 and ERK5 activation are essential for cell proliferation by asbestos. The use of a dominant-negative ERK5 construct caused selective downregulation of c-jun expression, whereas inhibition of Src by PP2 or MEK1 by PD98059 caused decreases in c-fos, fra-1 and c-jun expression in asbestos-exposed C10 cells. These observations may have broad relevance to cell proliferation by carcinogenic mineral fibers and oxidants.
Introduction
Asbestos is a naturally occurring mineral associated with the development of lung cancers, mesothelioma and asbestosis (Mossman et al., 1990; BeruBe et al., 1996; Mossman and Churg, 1998) . These proliferative diseases occur after initial cell injury and hyperplasia induced by asbestos fibers. Alveolar epithelial cells are critical cell types encountering asbestos fibers after inhalation, and their early injury and repair responses are thought to be central to the development of both malignant and nonmalignant lung disease. While the pathogenic outcomes of asbestos exposure have been well-documented, our understanding of the molecular effects of asbestos on alveolar epithelial cells remains incomplete.
Recently, cell injury and S-phase alterations by asbestos have been linked to phosphorylation of the epidermal growth factor receptor (EGFR) and the protracted activation of the extracellular signal-regulated (ERK1/2) pathway (Zanella et al., 1996 (Zanella et al., , 1999 Jimenez et al., 1997; Buder-Hoffmann et al., 2001) . Mitogen-activated protein kinase (MAPK) signal transduction pathways, including the extracellular signalregulated protein kinases (ERKs 1/2), c-Jun N-terminal kinases (JNKs), p38 and big mitogen kinase 1 (BMK1/ ERK5), are activated in response to various agents such as growth factors, tumor promoters and oxidants. ERK5, a more recently characterized member of the ERK family (Lee et al., 1995; Zhou et al., 1995) , is strongly activated by EGF as well as other receptor tyrosine kinases (Kamakura et al., 1999; Kato et al., 1998) , and is required for cell proliferation and progression through the cell cycle (Kamakura et al., 1999; Kato et al., 1998) . Downstream targets of the ERK5 pathway include the MAD-box transcription factor, MEF2C, which acts on the protooncogene c-jun promoter, and the SRE on the c-fos promoter.
Considering that phagocytosis of fibers and the high concentration of iron on the surface of crocidolite fibers may catalyse the formation of reactive oxygen species (ROS) that can interact with the EGFR and mediate cell proliferation and toxicity, we hypothesized that ERK5, a redox-sensitive kinase (Abe et al., 1999) could be an MAPK pathway contributing to asbestos-induced cell signaling in pulmonary epithelial cells. In these studies, a nontransformed murine C10 alveolar epithelial type II cell line (Malkinson et al., 1997) was used to determine the effect of crocidolite asbestos, H 2 O 2 , a conventional oxidant, and EGF on the ERK5 pathway. We show for the first time that asbestos, but not glass beads or the nonfibrous, chemically similar analog, riebeckite, causes protracted activation of ERK5 in an EGFR-independent and Src-dependent manner. Asbestos-induced ERK5 phosphorylation is inhibited in the presence of catalase. We also establish that Src is causally involved in the activation of ERK1/2 by asbestos via an EGFRdependent pathway. However, in contrast to H 2 O 2 and EGF, Tyr 1173 on the EGFR is not phosphorylated by asbestos. Our results are novel in that they are the first to illustrate a causal association between Src and ERK signaling by asbestos. Also, they demonstrate that the persistent Src and ERK signaling by asbestos fibers are critical to epithelial cell proliferation. These observations have broad relevance to understanding how proliferation might be controlled in asbestos-related lung diseases.
Results
Protracted ERK5 activation is unique to asbestos-exposed C10 cells EGF, a positive control in our studies and a mitogen in C10 cells (Buder-Hoffmann et al., 2001) , induced phosphorylation of ERK5 at 5 min, which returned to baseline levels at 2 h (Figure 1a, b) . These patterns correlated with ERK5 kinase activity using MBP as a substrate (Figure 1c, d) . A time and dose response experiment was then conducted with asbestos, EGF or H 2 O 2 to establish the effects of asbestos in comparison to these agents. As shown in Figure 2a , ERK5 phosphorylation by EGF or H 2 O 2 rose immediately, peaked around 20 min and returned to control levels at 1 h. Asbestos, on the other hand, caused later and more protracted activation of ERK5 phosphorylation, still increasing at 24 h. ERK5 phosphorylation by asbestos was dose-related ( Figure 2b ) and was inhibited with the addition of catalase, implying an oxidative mechanism involving H 2 O 2 (Figure 2c ). The observation that asbestos fibers, but not glass beads nor the nonfibrous analog, riebekite, induced ERK5 phosphorylation supports the concept that frustrated phagocytosis of asbestos fibers is a source of oxidant production relevant to ERK5 activation.
ERK5 activation by EGF, H 2 O 2 and asbestos is differentially blocked by small molecule inhibitors
To decipher the signaling pathways leading to ERK5 activation, C10 cells were treated with small molecule inhibitors prior to exposure to agents. Inhibition of EGFR phosphorylation with AG1478 (Mossman and Churg, 1998) blocked EGF-induced ERK5 activation (Pp0.05), but not H 2 O 2 effects (Figure 3 ). On the other hand, blockage of MEK1 phosphorylation with PD98059 did not inhibit ERK5 activation by EGF or H 2 O 2 . In contrast, the MEK1/2 and ERK5 inhibitor, U0126, completely blocked ERK5 activation by both agents. Finally, the PP2 inhhibitor of Src had the most dramatic effects on inhibition of ERK5 by asbestos as seen in Figure 4 by Western blot analysis (8 and 24 h), and confirmed in Figure 5 by kinase activity assays at 24 h. On the other hand, Figure 4 also shows that AG1478 and PD98059 were ineffective. None of the inhibitors alone nor the inactive control compound U0124 (data not shown) had any effects on ERK5 activity. 
ERK5 activation by asbestos is Src-dependent
As suggested in Figure 5 , the ERK5 activation by asbestos was dependent on Src using transfection of a dominant-negative Src (dnSrc) construct into C10 cells ( Figure 6 ). In these experiments, the cells transfected with an empty vector (controls) showed an increase in ERK5 phosphorylation after asbestos exposure, while the dnSrc-transfected cells did not.
ERK1/2 activation by asbestos is Src-and EGFR-dependent
To asssess the importance of Src in ERK1/2 signaling, small molecule inhibitors were evaluated in cells exposed to EGF, H 2 O 2 (Figure 7 ), or asbestos ( Figure 8 ). As seen in Figure 7 , EGF activation of the ERK1/2 pathway was suppressed by inhibition of EGFR phosphorylation and the MEK1/2 inhibitors, but only partially inhibited by PP2. On the other hand, the activation of ERK1/2 by H 2 O 2 was not abolished by the EGFR inhibitor, and only partially by the Src inhibitor, PP2. MEK1/2 inhibitors also abolished H 2 O 2 effects. In contrast, ERK1/2 activation after exposure of cells to asbestos ) at different times. Western blots were performed using total cell lysates, proteins were separated by denaturing gel electrophoresis, and then transferred onto nitrocellulose. ERK5 was detected using rabbit polyclonal anti-ERK5 and electrochemical luminescence. The signal was quantified by densitometry, and the ratio of phosphorylated to nonphosphorylated forms was calculated. Figure 4 ERK5 phosphorylation by asbestos is blocked by Src inhibition. Cells were grown to confluency in complete medium, then in a serum-free medium for 24 h before treatment with asbestos (5 ng/ml) for 8 and 24 h. (a) Western blots were performed from total cell lysates, proteins were separated by denaturing gel electrophoresis, and then transferred onto nitrocellulose. ERK5 was detected using a rabbit polyclonal anti-ERK5 antibody and electrochemical luminescence. (b) Blots were quantified by densitometry, and the ratio of phosphorylated to nonphosphorylated forms was calculated. *Pp0.05 in comparison to the control group for 4 or 24 h was suppressed by inhibiting EGFR phosphorylation or MEK1/2 ( Figure 8 ). ERK1/2 phosphorylation was totally abolished both in control empty vector and asbestos-exposed cells after transfection of dnSrc ( Figure 9 ). Taken together, data show that asbestos-induced activation of ERK1/2 is both EGFRand Src-dependent.
Src activation by asbestos precedes EGFR activation
A time frame study was then performed to determine whether Src was activated prior to phosphorylation of EGFR by asbestos. As seen in Figure 10a , the Src activation by asbestos starts at 1 min and peaks at 30 min to 1 h. In contrast, EGFR phosphorylation ( Figure 10b ) is not apparent until 2 h after initial exposure to asbestos fibers and is continuous for as long as 24 h.
Asbestos-induced activation of EGFR does not involve phosphorylation of Tyr 1173
Tyr 1173 is the major phosphorylation site whereby EGF activates the EGFR. As shown in Figure 11 , Tyr ERK5 phosphorylation is inhibited after transfection of a dnSrc construct. C10 cells were grown to 70-80% confluence and transfected with src (K296R/Y528F) in PUSEamp þ plasmid and control PUSEamp þ empty plasmid using Lipofectamine 2000. Cells were selected with G148 (300 mg/ml of media) 24 h after transfection for a period of 14 days. Cells were then maintained for 24 h in complete medium, then in a low serum medium for 24 h before exposure to asbestos (5 mg/cm 2 ) for 24 h. (a) Western blots were performed from total cell lysates, proteins were separated by denaturing gel electrophoresis and transferred onto nitrocellulose. ERK5 was detected using a rabbit polyclonal anti-ERK5 antibody and electrochemical luminescence. (b) Signals were quantified by densitometry, and the ratio of phosphorylated to nonphosphorylated forms was calculated. *Pp0.05 in comparison to the EV group Figure 7 ERK1/2 phosphorylation by EGF or H 2 O 2 is significantly blocked by Src inhibition. Cells were grown to confluency in medium, then in a low serum medium for 24 h before treatment with EGF (5 ng/ml) for 15 min or H 2 O 2 (200 mM) for 30 min. (a) Western blots were performed from total cell lysates, proteins were separated by denaturing gel electrophoresis and then transferred onto nitrocellulose. ERK1/2 was detected using rabbit polyclonal anti-ERK1/2 antibody and electrochemical luminescence. 1173 is not phosphorylated by asbestos. In contrast, both EGF and H 2 O 2 phosphorylate Tyr 1173, and this phosphorylation is inhibited by both agents in the presence of PP2 (10 mM). These results and the late and protracted patterns of EGFR phosphorylation observed in Figure 10b suggest that asbestos fibers have unique effects on EGFR phosphorylation, a subject for future investigation.
ERK1/2 and ERK5 pathways are both involved in asbestos-induced cell proliferation
Flow cytometry studies showed that the numbers of cells incorporating BrdU could be reduced by inhibition of small molecule inhibitors of Src and MEK1 (ERK1/2 pathway), and dnERK5 ( Figure 12 ). Use of the dnMEK1 construct was less effective in inhibiting responses than use of PD90859. Data suggest in concert that the ERK1/2 and ERK5 pathways are both important in asbestos-induced proliferation and that proliferation is also Src-dependent.
Inhibition of Src, ERK1/2 and ERK5 decreases the mRNA levels of AP-1 family members
As shown by RT-PCR (Figure 13a, b) , Src inhibition by PP2 (2 or 10 mM) or MEK1 inhibition by PD (30 mM) decreased asbestos-induced mRNA levels of fra-1, c-fos and c-jun. In contrast, use of a dominant-negative ERK5 construct selectively reduced the mRNA levels of c-jun (Figure 13c ). Inhibitors alone had no effects on baseline expression of these AP-1 components in cells.
Discussion
The insoluble mineral, crocidolite asbestos, is an inflammatory, fibrogenic and carcinogenic agent in the lung and pleura (Mossman et al., 1990; BeruBe et al., 1996; Mossman and Churg, 1998) . Epithelial cell injury, inflammation and fibrosis by asbestos is prevented in rodents by the administration of catalase (Mossman et al., 1990) or the iron chelator, phytic acid (Kamp et al., 1995) , supporting the role of ROS in the Figure 9 ERK1/2 phosphorylation is inhibited by transfection with a dnSrc construct. C10 cells were grown to 80-90% confluence, trypsinized, counted and resuspended. An aliquot of the cell suspension (400 ml) was mixed with 10 mg of plasmid DNA (expression src (K296R/Y528F) in PUSEamp þ plasmid and control PUSEamp þ empty plasmid (EV)) and electroporated. Cells were then maintained for 24 h in a complete medium, then in a serum-free medium for 24 h before exposure to asbestos (5 mg/ cm 2 ) for 24 h. Western blots were performed from total cell lysates, proteins were separated by denaturing gel electrophoresis and transferred onto nitrocellulose. ERK1/2 was detected using a rabbit polyclonal anti-ERK1/2 antibody and electrochemical luminescence Figure 10 Asbestos-induced phosphorylation of Src precedes that of EGFR. Cells were grown to confluency in a complete medium, then in a low serum medium for 24 h before exposure to asbestos (5 mg/cm 2 ) for different time periods. Panels show autoradiographs following SDS-PAGE of immunoprecipitated Src or EGFR using p60c-Src or angiotensin II, respectively, as substrates Figure 11 EGF and H 2 O 2 , but not asbestos, phosphorylate EGFR on pTyr 1173. Cells were grown to confluency in complete medium, then in a serum-free medium for 24 h before treatment with EGF (5 ng/ml) for 15 min and H 2 O 2 (200 mM) for 30 min or asbestos (5 mg/cm 2 ) for 24 h in the presence and absence of PP2 (10 mM). Western blots were performed from total cell lysates, proteins were separated by denaturing gel electrophoresis and then transferred onto nitrocellulose. pTYR 1173 was detected using a rabbit polyclonal anti-pTyr 1173 antibody and electrochemical luminescence Figure 12 Asbestos-induced proliferation is inhibited by blocking Src, ERK1/2 and ERK5 pathways. Incorporation of the thymidine analogue, BrdU and detection by flow cytometry was used to detect replicating cells. Numbers of BrdU-positive cells per total numbers of 7-AAD-positive cells were determined after assessment of samples in duplicate, and data were expressed as an average percentage value. Results are from a typical experiment that was performed in duplicate. *Pp0.05 in comparison to the untreated control group; þ Pp0.05 in comparison to the asbestos group Activation of ERK1/2 and ERK5 by asbestos L Scapoli et al pathogenesis of asbestos-associated lung disease. We have shown previously that asbestos, through an oxidant-dependent mechanism (Jimenez et al., 1997) , induces ERK1/2 kinases to initiate transcriptional events resulting in proliferation and/or apoptosis in target cells of the lung Robledo et al., 2000; Ramos-Nino et al., 2002a) . MAPK signaling cascades may be initiated at the cell surface after interaction of asbestos fibers with the EGFR, as long asbestos fibers cause aggregation of the EGFR (Pache et al., 1998) and induce its phosphorylation (Zanella et al., 1996) as well as its increased biosynthesis (Zanella et al., 1999) . Our work here focused on signaling pathways critical to MAPK activation by asbestos, a physiologically relevant oxidant stress ubiquitous in the environment, and the role of the EGFR and the Src pathway in these events. The ERK family consists of at least seven isoforms, and little is known about their regulation and function. We first show that ERK5, a redox-sensitive kinase known to mediate c-jun proto-oncogene expression and critically related to proliferation in other cell systems (Kato et al., 1998; Esparis-Ogando et al., 2002) , is activated by asbestos. Inducible ERK5 phosphorylation is observed in C10 epithelial cells in a time-and dosedependent manner after exposure to EGF, H 2 O 2 or crocidolite asbestos. In contrast to other agents, asbestos shows a more sustained response with a slower onset of induction. The protracted responses in ERK5 phosphorylation by asbestos resemble those observed for ERK1/2 (Buder-Hoffmann et al., 2001) , and may be due to the fact that asbestos fibers slowly settle on cells and are phagocytized or cycled between cells over time.
The use of small molecule inhibitors suggests that ERK5 activation by asbestos is similar to that of H 2 O 2 . The blockage of EGFR or MEK1/2 phosphorylation does not reduce ERK5 activation by asbestos or H 2 O 2 , implying an EGFR-independent pathway of activation. In contrast, ERK1/2 phosphorylation by asbestos, but not H 2 O 2 , is dependent on phosphorylation of the EGFR. These data, and those in Figure 11 showing lack of phosphorylation of Tyr 1173 by asbestos, but not H 2 O 2 , suggest that oxidant stresses differentially phosphorylate the EGFR, a phenomenon that may also cause different regulation of ERK pathways. Src phosphorylation has been mapped to at least five autophosphorylation and other sites on the EGFR receptor (Carpenter and Cohen, 1990) . A recent report suggests that Src-dependent phosphorylation of the EGFR on Tyr 845 is required for Zn-induced EGFR transactivation (Wu et al., 2002) . The mechanisms of EGFR phosphorylation by asbestos are undoubtedly complex, and may be related to its metal content or oxidant stress, and are beyond the scope of this report. However, aggregation of the external domain of the EGFR by asbestos fibers has been demonstrated previously (Pache et al., 1998) , and this may lead to dimerization and activation as has been demonstrated with various cations (Mohammadi et al., 1993) .
Src involvement has been implicated in signaling from many receptors, including the EGFR, although the interactions between Src and the EGFR are multidimensional and poorly understood (Abram and Courtneidge, 2000) . Our work is the first to show that Src is essential for the activation of both ERK1/2 and ERK5 by asbestos. In addition, ERK1/2 and ERK5 Figure 13 Taqman results show that (a) treatment of C10 cells with PP2 (10 mM), inhibits the asbestos-induced gene expression of cfos, fra-1 and c-jun; (b) inhibition of MEK1 by PD98059 (30 mM) also decreases mRNA expression of c-fos, fra-1 and c-jun, while (c) asbestos-induced c-jun expression is selectively diminished using a dominant-negative ERK5 cell line. Prior to TaqMan analysis, RNA was reverse transcribed into cDNA. FRET from 6-FAM was detected and quantitated by the ABI Prism 7700 Sequence Detection System. Coamplification of the endogenous housekeeping gene, hprt, was used to normalize the data. *Pp0.05 in comparison to the control group Activation of ERK1/2 and ERK5 by asbestos L Scapoli et al phosphorylation by EGF or H 2 O 2 is significantly inhibited by the PP2 Src inhibitor. It has been suggested that Src binds directly to the EGFR, leading to the activation of Src and Src phosphorylation of the EGFR at sites that hyperactivate the kinase activity of the EGFR (Abram and Courtneidge, 2000) . The data in Figure 10 , showing that phosphorylation of Src occurs prior to phosphorylation of the EGFR, are consistent with the hypothesis that Src phosphorylates the EGFR, a requirement for ERK1/2 phosphorylation. Alternatively, Src activation of ERK5 could be downstream of the EGFR and mediated by other kinases.
As is clear from Figure 12 , Src, ERK1/2 and ERK5 are all important in asbestos-induced proliferation and this may be the result of increases in the mRNA levels of AP-1 family members as shown in Figure 13 . The ERK5 pathway may be contributing selectively to the regulation of c-jun, whereas both the Src ERK1/2 pathways may regulate c-fos, fra-1 and c-jun. We have recently linked ERK1/2-dependent fra-1 expression to mesothelial cell transformation by asbestos (Ramos-Nino et al., 2002b , 2003 and the protracted expression of this gene may be a result of initial increases in c-fos and c-jun (Shukla et al., 2001; Ramos-Nino et al., 2002b , 2003 . Figure 14 presents a hypothetical schema for the findings reported here and our previous work showing that ERK1/2 expression precedes the advent of DNA synthesis in C10 cells exposed to asbestos (Buder-Hoffmann et al., 2001) . Asbestos fibers cause aggregation of the EGFR, a phenomenon leading to phosphorylation of the EGFR (Zanella et al., 1996 (Zanella et al., , 1999 , which is critical to ERK1/2 activation. Alternatively, Src activation by asbestos (or H 2 O 2 and EGF) may lead to phosphorylation of the EGFR and/or downstream events linked to ERK5 phosphorylation. These events and the possible synergy between Src-and EGFR-dependent signaling are critical to cell proliferation as indicated here and in other studies (Biscardi et al., 1998; Thiery and Chopin, 1999) . The demonstration that ERK1/2 and ERK5 pathways are Src-dependent, but differentially regulated by phosphorylation of the EGFR, is a novel finding and may have broad implications to the control of cell injury and abnormal cell proliferation by environmental oxidants.
Materials and methods
Cell culture and reagents C10 cells were maintained and passaged in CMRL 1066 medium (Life Technologies, Inc., Grand Island, NY, USA), supplemented with 10% fetal bovine serum (FBS), 2 mM Lglutamine, and antibiotics. At confluence, cells were switched to 0.5% FBS-containing medium for 24 h prior to the addition of crocidolite asbestos [Na 2 (Fe 3 þ ) 2 (Fe 2 þ ) 3 Si 8 O 22 (OH) 2 ] (NIEHS reference sample) at 5 mg/cm 2 dish, EGF (Upstate Biotechnology, Lake Placid, NY, USA) at 5 ng/ml or H 2 O 2 (200 mM). The fiber dimensions and characterization of the respirable asbestos preparation, which has a mean fiber diameter of 0.4 mm and a length of 4.36 mm, has been reported previously (Campbell et al., 1980) . Glass beads (4 mm in diameter) and riebeckite particles (p5 mm in diameter) were used as control, nonpathogenic particles. All particulates were weighed and suspended at 1 mg/ml in Hank's balanced salt solution (HBSS) (Life Technologies, Inc., Grand Island, NY, USA) before addition at noncytolytic concentrations to culture dishes (Zanella et al., 1996; Jimenez et al., 1997) . The MEK1/2 inhibitor, PD98059 (30 mM) (Buder-Hoffmann et al., 2001) , U0126 (10 mM) which also inhibits ERK5 (Favata et al., 1998) , the specific inhibitor of EGFR tyrosine kinase activity, tyrphostin AG1478 (10 mM) (Levitzki and Gazit, 1995) and the Src family-inhibitor, PP2 (10 mM) (all obtained from Calbiochem, La Jolla, CA, USA) were added in dimethyl Figure 14 A hypothetical schema for mechanisms of asbestos-induced ERK5 and ERK1/2 activation supported by our data Activation of ERK1/2 and ERK5 by asbestos L Scapoli et al sulfoxide (DMSO, 0.1% final concentration in medium). Cells were preincubated with individual compounds 1 h before the addition of EGF, H 2 O 2 or particulates. Sham control dishes (in medium containing 0.1% DMSO) were treated identically.
Western blot analyses for phosphorylated ERKs
Cells were washed 3 Â with cold phosphate-buffered saline (PBS) before centrifugation at 14 000 r.p.m. for 1 min. The pellet was resuspended in lysis buffer (20 mM Tris (pH 7.4), 1% Triton X-100, 10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 2 mM pyrophosphate, 1 mM PMSF, 10 mg/ml leupeptin, 1 mM DTT, 10 mM NaF, 1% aprotinin), incubated at 41C for 15 min and centrifuged at 14 000 r.p.m. for 20 min. The amount of protein in each supernatant was determined using the Bio-Rad protein assay (Bio-Rad, Hercules, CA, USA). Protein (40 mg) in sample buffer (62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl sulfate (SDS), 10% glycerol, 50 mM dithiothreitol, 0.1% w/v bromophenol blue) was electrophoresed in 10% SDS-polyacrylamide gels (PAGE), and transferred onto nitrocellulose using a semidry transfer apparatus (Ellard Instrumentation, Ltd, Seattle, WA, USA). Blots were blocked in buffer (Tris-buffered saline (TBS) containing 5% nonfat dry milk plus 0.1% Tween-20 (Sigma)) for 1 h, washed 3 Â for 5 min each in TBS 0.1% Tween and incubated at 41C with antibodies specific to: (1) phosphorylated ERK1/2 (phosphop44/42 MAPK (Thr 202/Tyr 204 (New England Biolabs, MA, USA)) at 1 : 1000 in TBS containing 1% BSA; (2) total ERK (p44/42 MAPK (Santa Cruz Biotechnology, CA, USA)); (3) phosphorylated and nonphosphorylated ERK5 at 1 : 1000 (Santa Cruz Biotechnology, CA, USA); (4) phosphorylated Src (Y416) and nonphosphorylated Src at 1 : 1000 (Upstate Biotechnology, Lake Placid, NY, USA); and (5) nonphosphorylated EGFR (1005) or phosphorylated EGFR (Y1173) at 1 : 2000 (Santa Cruz Biotechnology, CA, USA). Blots were then washed 3 Â with TBS/0.1% Tween-20 and incubated with a specific peroxidase-conjugated secondary antibody for 1 h. After washing blots 3 Â in TBS/0.1% Tween-20, protein bands were visualized with the LumiGlo-enhanced chemiluminescence detection system (Kirkgaard and Perry Laboratories, Gaithersburg, MD, USA). Blots were quantitated by densitometry and ERK5 phosphorylation was expressed as a ratio of phosphorylated ERK5 over nonphosphorylated ERK5 for each sample.
Kinase activity assays
Specific protein kinases were immunoprecipitated from wholecell lysates (300 mg) with 2 mg ERK5 antibody, EGFR (1005) antibody, or c-Src antibody, then washed and incubated for 20 min at 301C in kinase buffer (20 nM HEPES, pH 7.5, 2 mM 2-mercaptoethanol, 5 mM MgCl 2 ) containing 5 mCi [g-32 P]ATP and 5 mg myelin basic protein (MBP) per reaction as a substrate for ERK5, angiotensin II for EGFR, and p60 c-Src (both from Calbiochem, La Jolla, CA, USA) for Src. Incorporation of the 32 P into substrate was visualized by autoradiography following SDS-PAGE and quantified using phosphoimaging (Bio-Rad Multi-Analysis program).
Transfections
The C10 cells were grown to 70-80% confluence and transfected using Lipofectamine 2000 as recommended by the manufacturer (Invitrogen, Carlsbad, CA, USA). The constructs used for transfection were Src (K296R/Y528F) in PUSEamp þ plasmid and control PUSEamp þ empty plasmid (Upstate Biotechnology, Lake Placid, NY, USA), dnBMK1 (AEF) (BMK1 Thr218 and Tyr 220 mutated to alanine and phenylalanine, respectively) (kindly donated by Dr Jiing-Dwan Lee, Scripps Research Institute, La Jolla, CA, USA) (Kato et al., 1997) and dnMEK1 (Mutations S218V/S222V) in pVL1392 (Invitrogen Life Technologies, Carlsbad, CA, USA) cotransfected with pSV2neo (BD Clontech, Palo Alto, CA, USA) for neomycin resistance. Cells were selected with G418 (300 mg/ml of media) 24 h after transfection for a period of 14 days.
Incorporation of 5-bromodeoxyuridine (BrdU) using flow cytometry Incorporation of the thymdine analogue, BrdU, was used to evaluate C10 cell proliferation. For detection of numbers of cells incorporating BrdU, cells were plated, grown to confluency before maintenance in low serum medium for 24 h, and exposed to asbestos and 10 mM BrdU as described above for 24 h. The cells were harvested according to the manufacturer's instructions using the BrdU Flow Kit protocol (BD Biosciences, Pharmingen, San Diego, CA, USA). The samples were stained with FITC-labeled anti-BrdU antibody and with a dye (7-AAD) that binds total DNA before filtration with a 53 mm nylon mesh to eliminate cell clumps (Small Parts Inc., Miami, FL, USA). Fluorescence was detected using a 488 nm argon laser by flow cytometry (Epics XL Coulter flow cytometer, Spectron Co., Washington, DC, USA). The numbers of BrdU-positive cells per total numbers of 7-AADpositive cells were determined after assessment of samples in duplicate, and data were expressed as an average percentage value.
RNA extraction
Total RNA was prepared using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer's protocol. After the ethanol precipitation step in the TRIzol extraction procedure, a cleanup was carried out using the Rneasy Total RNA Isolation kit (Qiagen, Valencia, CA, USA).
RT-PCR using TaqMan approaches mRNA expression was assayed quantitatively via real-time PCR using TaqMan. Prior to TaqMan analysis, RNA was reverse transcribed into cDNA using MMLV reverse transcriptase following the manufacturer's instructions (GIBCO-BRL). Copy numbers of cDNA targets were characterized by Oligo name Primers and probes c-jun-forward gaaaaccttgaaagcgcaaaac c-jun-reverse cacctgttccctgagcatgttc c-jun-probe ccgagctggcatccacggc fra-1-forward dtgccttgcatctccctttct fra-1-reverse tcagagagggtgtggtcatgag fra-1-probe cccgtacttgaaccggaagcactgc c-fos-forward aatccagggaggccacaga c-fos-reverse ccgacctgcctgcaagat c-fos-probe tctcctctgggaagccaaggtcatcg hprt-forward tttgccgcgagccg hprt-reverse taacctggttcatcatcgctaatc hprt-probe cgacccgcagtcccagcgtc Activation of ERK1/2 and ERK5 by asbestos L Scapoli et al the point during cycling when PCR product is first detected. TaqMan probes and primers were designed that specifically bind to mouse gene sequences of interest (Table 1) . The probe contained a 5 0 fluorescent reporter dye (6-FAM) and a 3 0 quencher dye (TAMRA), which in close proximity represses fluorescence in the intact probe. As the polymerization of the primers is extended, strand displacement and cleavage of the 5 0 reporter from the quencher dye increases fluorescence resonance energy transfer (FRET) from 6-FAM as detected and quantitated by the ABI Prism 7700 Sequence Detection System (Perkin Elmer Corp., Foster City, CA, USA). Data were analysed as described previously (Ramos-Ninos et al., 2003) . Coamplification of an endogenous housekeeping gene (hprt) was used to normalize the differences in cDNA copies between samples.
Statistical analysis
All data were examined by Dr Pamela Vacek (Department of Medical Biostatistics, University of Vermont Biometry Facility) using ANOVA to adjust for multiple pairwise comparisons between groups. All experiments examined samples in duplicate and were repeated two to three times.
